S.African drug firm to commercialise mood-boosting plant

Afp
Tuesday 05 October 2010 12:45 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

South Africa's government on Friday handed a pharmaceutical company a permit to commercialise a plant used as a mood elevator by indigenous groups.

The permit allows Sceletium tortuosum, which has been used for centuries in the Western Cape, to be researched and commercialised by HGH Pharmaceutical, a South African company.

The company believes the plant possesses anti-stress, anti-anxiety and anti-depressive capabilities, and it has developed an extract product.

"It looks extremely promising," said research scientist Nigel Gericke. "These claims would have to be scientifically validated obviously."

The plant, known locally as "kanna" or "kougoed", is used by the indigenous Khoi and San communities as a sedative, mood booster, and hunger and thirst suppressant.

"There's a huge range of traditional uses," Gericke said.

The license was granted last December but officially handed over on Friday at a ceremony in the Western Cape province, where the plant naturally occurs.

The permit gives the company - which has researched and cultivated the plant for eight years - the right to continue its research, export plant material and extract, and commercialise the product.

jg/jhb/cg

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in